Insulin glargine U100

DRUG5 trials

Sponsors

Novo Nordisk A/S, Sanofi, Gan & Lee Pharmaceuticals.

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Type 1 Diabetes Mellitus

Phase 1

A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week

CompletedNCT03766854

Novo Nordisk A/SDiabetes Mellitus, Type 1

Start: 2018-12-07End: 2019-12-09Updated: 2021-03-08

Phase 2

A Research Study in People With Type 2 Diabetes to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine

CompletedNCT03922750

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2019-05-09End: 2020-01-27Updated: 2022-01-18

Phase 3

A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes

CompletedNCT03689374

Novo Nordisk A/SDiabetes Mellitus, Type 2

Start: 2018-10-01End: 2021-02-22Updated: 2022-11-14

Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

CompletedNCT03874715

SanofiType 1 Diabetes Mellitus

Start: 2019-03-11End: 2020-07-08Updated: 2024-04-17

A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)

Active, not recruitingNCT06767735

Gan & Lee Pharmaceuticals.Diabetes

Start: 2025-02-17End: 2026-08-17Target: 580Updated: 2025-11-28

Related Papers

Effect of once‐weekly semaglutide versus thrice‐daily insulin aspart, both as add‐on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes ( <scp>SUSTAIN</scp> 11): A randomized, open‐label, multinational, phase 3b trial

Diabetes Obesity and Metabolism2022-05-1262 citations

Abstract 5: Similar hypoglycemia duration with once-weekly insulin icodec versus insulin glargine U100 in insulin naïve or experienced patients with T2D

Indian Journal of Endocrinology and Metabolism2022-03-01

191-OR: Similar Hypoglycemia Duration with Once-Weekly Insulin Icodec vs. Insulin Glargine U100 in Insulin Naïve or Experienced Patients with T2D

Diabetes2021-06-015 citations

731-P: CGM-Based Measurements for Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 in Insulin-Treated Patients with T2D: A Post-hoc Analysis

Diabetes2021-06-011 citations